In this presentation to the BPI Theater at BIO on Wednesday, 5 June 2019, Kiran Chin introduced MKA Insights, a new firm focused on helping bioprocess, life science, clinical diagnostics, and gene therapy companies accelerate their growth. Although there’s no shortage of information on data processes, Chin has found that many companies neglect fundamentals that drive commercialization strategies. Many executives dive in without asking basic questions — ones that Chin brings to the fore: Why do we exist? What are…

On Wednesday, 5 June 2019, Letian Kuai delivered a presentation to the BPI Theater at BIO about the role of machine learning in drug design. In many cases, Kuai said, drugs are developed by accident. Researchers are beginning to leverage artificial intelligence to make those accidents occur more quickly and predictably. To that end, WuXi has developed a DNA encoded library (DEL) platform based on combinatorial chemistry principles and bolstered by artificial intelligence. This technology, Kuai suggests, could enable unprecedented…

Eric Langer, President of BioPlan Associates, joined the BPI Theater at BIO on Wednesday, 5 July 2019, to report recent movements in China’s biopharmaceutical markets. In collaboration with the Society for Industrial Microbiology (SIM) and 102 different authors from around the world, BioPlan conducted a peer-reviewed analysis of the factors driving product development in China. Results showed that market data are not the biggest factor; it is the high incidence of cancer diagnosis and death. Considering this great need and…